A study was carried out to evaluate the impact of dietary onion powder (OP) on growth performance, serum biochemistry, gut morphology, and immune response
Industry development with potential relevance for veterinary professionals, companion animal care, and animal health stakeholders.
Strong U.S. demand and new product launches drive first-half sales in Human Pharma Net sales reach EUR 15.8 billion, led by JARDIANCE® and successful U.S.
New university findings highlight potential implications for veterinary patients, cancer, and veterinary practice.
Researchers at Texas A&M VMBS have reported new findings related to cancer. The report, centered on “Tiny Molecules, Big Possibilities: Texas A&M Researchers...
New university findings highlight potential implications for swine, animal health, and veterinary practice.
Researchers at Texas A&M VMBS have reported new findings related to animal health. The report, centered on “Texas A&M Researchers Map Tick Habitat to Strengt...
Clinical evidence update from Animals : an open access journal from MDPI
Myxomatous mitral valve disease (MMVD) is the most common acquired cardiac disease in small-breed dogs and shows particularly high prevalence and early
New university findings highlight potential implications for dogs, cancer, and veterinary practice.
Researchers at Washington State University College of Veterinary Medicine have reported new findings related to cancer. The report, centered on “Winnie on wh...
Pet Owner Educational Atlas. Diagnosis in Dermatology is an Edra professional veterinary reference focused on clinical practice, education and treatment planning.
Clinical evidence update from Journal of veterinary internal medicine
In people with chronic kidney disease (CKD), inadequate renal ammonia excretion contributes to metabolic acidosis and is associated with worse outcomes.
Industry development with potential relevance for veterinary professionals, companion animal care, and animal health stakeholders.
Dublin, July 06, 2026 (GLOBE NEWSWIRE) -- The "Veterinary Pharmaceutical Submissions in the EU (London, United Kingdom - Nov 19th - Nov 20th, 2026)" has
